FDA Enforcement Class II Completed

LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

Recall: Z-1283-2024 · Reported March 20, 2024

Enforcement

Recall Number
Z-1283-2024
Event ID
93968
Classification
Class II
Status
Completed
Product Type
Devices
Firm
Fresenius Kabi USA, LLC
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Other
Report Date
March 20, 2024
Initiation Date
May 10, 2023
Classification Date
March 11, 2024
Address
50 High St Ste 50, N/A, North Andover, MA, 01845-2620, United States

Description

LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

Reason

Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.

Code Info

UDI-DI 00811505030122 Software versions 5.2.1/5.2.2

Distribution

US Nationwide distribution to the states of CA, CO, NJ, WI, UT.

Quantity

6 US